Comparative effectiveness of pemafibrate versus bezafibrate on hepatic and vascular endothelial function in patients with coronary artery disease and metabolic dysfunction-associated steatotic liver disease.

Front Endocrinol (Lausanne) · 2026 · PMC12932250 · PMID 41757235

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

For instance, the difference in ALT was primarily evident in Period 2, and the difference in creatinine did not reach statistical significance in either individual period ( Supplementary Table 3 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.